Shell said it has agreed to buy Canada’s ARC Resources in a deal valued at $16.4 billion. The transaction is expected to boost Shell’s long-term oil and gas production. ARC Resources is a company ...

AMSTERDAM, April 21 (Reuters) - A Dutch climate activist group launched a new court case against Shell (SHEL.L), opens new tab on Tuesday in ‌the Netherlands, demanding that the British energy major ...

1:26 Energy giant Shell expands in Canada with $22B deal; what it means? Global energy heavyweight Shell PLC’s plan to buy one of Canada’s biggest natural gas producers bolsters the likelihood an ...

LONDON, April 27 (Reuters) - Shell (SHEL.L), opens new tab has agreed to buy Canadian energy company ARC Resources (ARX.TO), opens new tab in a $16.4 billion deal, paid for mostly with shares, the ...

British energy giant Shell is facing a new legal challenge in the Netherlands, as a Dutch climate activist group demands an immediate end to its investments in new oil and gas projects. The lawsuit ...

Oil giant Shell has signed a $22-billion deal to acquire ARC Resources Ltd., bringing together the lead partner in Canada's first operating liquefied natural gas project with a major producer in one ...

The cult-favorite Kansas City taco shells are back at Walmart — that is, if you can get your hands on them. La Tiara, a local taco shell brand, has been a staple of Kansas City taco nights since 1960.

Like most Americans who express themselves primarily through carefully arranged seashells, I was shocked and frightened to learn the Trump administration has indicted former FBI Director James Comey ...

Former FBI Director James Comey was indicted on Tuesday on charges of making threats against President Donald Trump related to a photograph he posted on social media last year of seashells arranged in ...

The Justice Department secured an indictment Tuesday charging former FBI Director James Comey with threatening the life of President Donald Trump by posting a photo of seashells on Instagram.

Recently, a pharmaceutical company came to the antibody-discovery specialist, Abveris, with a serious problem. The pharmaceutical company had tried and failed to develop a monoclonal antibody for an ...